Hypofractionated Accelerated Chemo-radiotherapy (Chemo-HypoAR) With Cisplatin and Liposomal Doxorubicin for the Treatment of Patients With Uterine Sarcomas

Conclusion: Concurrent hypofractionated and accelerated chemo-radiotherapy (chemo-HypoAR) is feasible and provides excellent survival figures.

Source: In Vivo - August 29, 2019 Category: Research Authors: DOMOXOUDIS, S., KOUKOURAKIS, I. M., GIAKZIDIS, A. G., KOUKOURAKIS, M. I. Tags: Clinical Studies Source Type: research